What is the indication for the immediate-release (IR) form of Trazodone?

The immediate-release (IR) form of Trazodone is primarily indicated for the treatment of sleep disorders, particularly insomnia. Trazodone is an antidepressant that, due to its sedative effects, has been widely used off-label for managing sleep issues. The pharmacological properties of Trazodone include its ability to block certain serotonin receptors, which can lead to increased drowsiness, making it effective in helping individuals who struggle with falling or staying asleep. While Trazodone is also used to treat depression and can have benefits in anxiety management, the IR formulation is specifically noted for its efficacy in addressing sleep problems rather than serving as a primary treatment for anxiety or pain relief. Thus, the focus on insomnia management underlines the intended use of the IR form of Trazodone in clinical practice.